UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Detection of Mutations in SF3B1 in Chronic Lymphocytic Leukaemia Patients By Reverse Transcription (Rt) Polymerase Chain Reaction and High Resolution Melt Curve Analysis, an Alternative Approach to Next Generation Sequencing for Routine Molecular Diagnostic Laboratories?

Blood, 2015-12, Vol.126 (23), p.5283-5283

2015

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial

Blood, 2014-08, Vol.124 (6), p.891-898

2014

Link zum Volltext

Verfügbarkeit prüfen

Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses

Blood, 2015-02, Vol.125 (7), p.1107-1115

2015

Link zum Volltext

Verfügbarkeit prüfen

Progress toward inducing immunologic tolerance to factor VIII

Blood, 2013-05, Vol.121 (22), p.4449-4456

2013

Link zum Volltext

Verfügbarkeit prüfen

EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress

Blood, 2012-09, Vol.120 (12), p.2501-2511

2012

Link zum Volltext

Verfügbarkeit prüfen

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

Blood, 2023-09, Vol.142 (11), p.989

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World IgG Testing Frequency and Characteristics Associated with Hypogammaglobulinemia after Anti-CD20 Exposure in Patients with Chronic Lymphocytic Leukemia (CLL)

Blood, 2020-11, Vol.136 (Supplement 1), p.43-44

2020

Link zum Volltext

Verfügbarkeit prüfen

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

Blood, 2022-11, Vol.140 (Supplement 1), p.2240-2241

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Calbindin 1 (CALB1) Rescues Erythropoiesis in a Human Model of Diamond Blackfan Anemia: Implications for Novel Therapies

Blood, 2020-11, Vol.136 (Supplement 1), p.4-4

2020

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Results of a Phase 1 Study in Healthy Subjects Administered Inclacumab, a Fully Human IgG4 Anti-P-Selectin Monoclonal Antibody in Development for Treatment of Sickle Cell Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.977-977

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Multiple Myeloma Patients at Mayo Clinic

Blood, 2021-11, Vol.138 (Supplement 1), p.2717-2717

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Clinical Cytokine Panel Profiles As Diagnostic and Prognostic Biomarkers in Pediatric Hyperinflammatory Conditions

Blood, 2022-11, Vol.140 (Supplement 1), p.8341-8342

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcend CLL 004: Phase 1 Cohort of Lisocabtagene Maraleucel (liso-cel) in Combination with Ibrutinib for Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Blood, 2020-11, Vol.136 (Supplement 1), p.39-40

2020

Link zum Volltext

Verfügbarkeit prüfen

The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.8-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Application of a Standardized Flow Cytometry Panel for Defining and Monitoring the Immunophenotype of CAR-T Cells

Blood, 2019-11, Vol.134 (Supplement_1), p.5626-5626

2019

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP

Blood, 2019-11, Vol.134 (Supplement_1), p.921-921

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(5)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Detection of Mutations in SF3B1 in Chronic Lymphocytic Leukaemia Patients By Reverse Transcription (Rt) Polymerase Chain Reaction and High Resolution Melt Curve Analysis, an Alternative Approach to Next Generation Sequencing for Routine Molecular Diagnostic Laboratories?

A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma: Promising Activity and Manageable Toxicity, Including in High Risk Disease

Minimal Residual Disease (MRD) Status in FCR-Treated CLL Patients at the End of Treatment Influences Progression Free Survival (PFS), Results of the Ctrial-IE (ICORG) 07-01/ CLL Ireland Study, with Mutational Analysis Providing Additional Insight

A Phase II Multi-Center Study of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma - Ctrial-IE (ICORG) 13-17 Study

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial

Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses

Progress toward inducing immunologic tolerance to factor VIII

EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

Real-World IgG Testing Frequency and Characteristics Associated with Hypogammaglobulinemia after Anti-CD20 Exposure in Patients with Chronic Lymphocytic Leukemia (CLL)

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

Targeting of Calbindin 1 (CALB1) Rescues Erythropoiesis in a Human Model of Diamond Blackfan Anemia: Implications for Novel Therapies

Preliminary Results of a Phase 1 Study in Healthy Subjects Administered Inclacumab, a Fully Human IgG4 Anti-P-Selectin Monoclonal Antibody in Development for Treatment of Sickle Cell Disease

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Multiple Myeloma Patients at Mayo Clinic

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

Recurrent Copy Number Alterations Contribute to a Unique Genetic Landscape in Relapsed-Refractory DLBCL

Analysis of Clinical Cytokine Panel Profiles As Diagnostic and Prognostic Biomarkers in Pediatric Hyperinflammatory Conditions

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

Transcend CLL 004: Phase 1 Cohort of Lisocabtagene Maraleucel (liso-cel) in Combination with Ibrutinib for Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Application of a Standardized Flow Cytometry Panel for Defining and Monitoring the Immunophenotype of CAR-T Cells

Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP

Aktive Filter

Suchergebnisse filtern